Diana Hom Quon

Title: Diana Hom Quon: Innovator in Alzheimer's Disease Research

Introduction

Diana Hom Quon is a prominent inventor based in Redwood City, CA (US). She has made significant contributions to the field of neuroscience, particularly in the study and treatment of Alzheimer's disease. With a total of 4 patents to her name, her work focuses on innovative methods to inhibit the production of amyloid-beta, a key factor in the progression of Alzheimer's.

Latest Patents

One of her latest patents is titled "Inhibition of Aβ production by β-secretase BACE2." This invention is based on the discovery that BACE2, a homolog of β-secretase BACE, can stimulate the processing of APP in a non-amyloidogenic pathway, thereby reducing the levels of Aβ. The methods and means provided in this patent offer potential candidates for treating Alzheimer's disease and other neurological disorders by decreasing β-amyloid deposit formation. Another significant patent is "β-secretase and modulation of β-secretase activity." This invention introduces a novel β-secretase and outlines a method for its partial purification. It also describes its application in screening assays for potential drug candidates targeting Alzheimer's disease and other neurological conditions.

Career Highlights

Diana has worked with notable companies such as Scios Inc. and Eli Lilly and Company. Her experience in these organizations has contributed to her expertise in drug development and neurological research.

Collaborations

Diana has collaborated with esteemed colleagues, including Barbara Cordell and Yu-Wang Liu, to advance her research and innovations in the field.

Conclusion

Diana Hom Quon is a trailblazer in Alzheimer's disease research, with her patents paving the way for new therapeutic approaches. Her work exemplifies the impact of innovation in addressing complex neurological challenges.